1351 related articles for article (PubMed ID: 21752789)
1. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
[TBL] [Abstract][Full Text] [Related]
2. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS.
Ke YD; van Hummel A; Stevens CH; Gladbach A; Ippati S; Bi M; Lee WS; Krüger S; van der Hoven J; Volkerling A; Bongers A; Halliday G; Haass NK; Kiernan M; Delerue F; Ittner LM
Acta Neuropathol; 2015 Nov; 130(5):661-78. PubMed ID: 26437864
[TBL] [Abstract][Full Text] [Related]
3. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
Mackenzie IR; Rademakers R
Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
[TBL] [Abstract][Full Text] [Related]
4. Withania somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration.
Dutta K; Patel P; Rahimian R; Phaneuf D; Julien JP
Neurotherapeutics; 2017 Apr; 14(2):447-462. PubMed ID: 27928708
[TBL] [Abstract][Full Text] [Related]
5. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.
Maekawa S; Leigh PN; King A; Jones E; Steele JC; Bodi I; Shaw CE; Hortobagyi T; Al-Sarraj S
Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940
[TBL] [Abstract][Full Text] [Related]
6. A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies.
Lashley T; Rohrer JD; Bandopadhyay R; Fry C; Ahmed Z; Isaacs AM; Brelstaff JH; Borroni B; Warren JD; Troakes C; King A; Al-Saraj S; Newcombe J; Quinn N; Ostergaard K; Schrøder HD; Bojsen-Møller M; Braendgaard H; Fox NC; Rossor MN; Lees AJ; Holton JL; Revesz T
Brain; 2011 Sep; 134(Pt 9):2548-64. PubMed ID: 21752791
[TBL] [Abstract][Full Text] [Related]
7. The role of mutant TAR DNA-binding protein 43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Janssens J; Kleinberger G; Wils H; Van Broeckhoven C
Biochem Soc Trans; 2011 Aug; 39(4):954-9. PubMed ID: 21787329
[TBL] [Abstract][Full Text] [Related]
8. Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43.
Uchida A; Sasaguri H; Kimura N; Tajiri M; Ohkubo T; Ono F; Sakaue F; Kanai K; Hirai T; Sano T; Shibuya K; Kobayashi M; Yamamoto M; Yokota S; Kubodera T; Tomori M; Sakaki K; Enomoto M; Hirai Y; Kumagai J; Yasutomi Y; Mochizuki H; Kuwabara S; Uchihara T; Mizusawa H; Yokota T
Brain; 2012 Mar; 135(Pt 3):833-46. PubMed ID: 22252998
[TBL] [Abstract][Full Text] [Related]
9. Loss of TDP-43 causes age-dependent progressive motor neuron degeneration.
Iguchi Y; Katsuno M; Niwa J; Takagi S; Ishigaki S; Ikenaka K; Kawai K; Watanabe H; Yamanaka K; Takahashi R; Misawa H; Sasaki S; Tanaka F; Sobue G
Brain; 2013 May; 136(Pt 5):1371-82. PubMed ID: 23449777
[TBL] [Abstract][Full Text] [Related]
10. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
[TBL] [Abstract][Full Text] [Related]
11. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
[TBL] [Abstract][Full Text] [Related]
12. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration.
Wils H; Kleinberger G; Janssens J; Pereson S; Joris G; Cuijt I; Smits V; Ceuterick-de Groote C; Van Broeckhoven C; Kumar-Singh S
Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3858-63. PubMed ID: 20133711
[TBL] [Abstract][Full Text] [Related]
13. Evidence that TDP-43 is not the major ubiquitinated target within the pathological inclusions of amyotrophic lateral sclerosis.
Sanelli T; Xiao S; Horne P; Bilbao J; Zinman L; Robertson J
J Neuropathol Exp Neurol; 2007 Dec; 66(12):1147-53. PubMed ID: 18090923
[TBL] [Abstract][Full Text] [Related]
14. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR
Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723
[TBL] [Abstract][Full Text] [Related]
15. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.
Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM
Acta Neuropathol Commun; 2017 Oct; 5(1):76. PubMed ID: 29078806
[TBL] [Abstract][Full Text] [Related]
16. [Frontotemporal lobar degeneration with TDP-43-positive inclusions and amyotrophic lateral sclerosis with dementia].
Kishimoto Y; Yokota O; Takeda N; Ikeda C; Arai T
Nihon Rinsho; 2011 Dec; 69 Suppl 10 Pt 2():384-8. PubMed ID: 22755219
[No Abstract] [Full Text] [Related]
17. Primary lateral sclerosis: upper-motor-predominant amyotrophic lateral sclerosis with frontotemporal lobar degeneration--immunohistochemical and biochemical analyses of TDP-43.
Kosaka T; Fu YJ; Shiga A; Ishidaira H; Tan CF; Tani T; Koike R; Onodera O; Nishizawa M; Kakita A; Takahashi H
Neuropathology; 2012 Aug; 32(4):373-84. PubMed ID: 22098653
[TBL] [Abstract][Full Text] [Related]
18. TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients.
Scialò C; Tran TH; Salzano G; Novi G; Caponnetto C; Chiò A; Calvo A; Canosa A; Moda F; Caroppo P; Silani V; Ticozzi N; Ratti A; Borroni B; Benussi L; Ghidoni R; Furlanis G; Manganotti P; Senigagliesi B; Parisse P; Brasselet R; Buratti E; Legname G
Brain Commun; 2020; 2(2):fcaa142. PubMed ID: 33094285
[TBL] [Abstract][Full Text] [Related]
19. Neuronal intermediate filaments and ALS: a new look at an old question.
Xiao S; McLean J; Robertson J
Biochim Biophys Acta; 2006; 1762(11-12):1001-12. PubMed ID: 17045786
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U.
Tsai KJ; Yang CH; Fang YH; Cho KH; Chien WL; Wang WT; Wu TW; Lin CP; Fu WM; Shen CK
J Exp Med; 2010 Aug; 207(8):1661-73. PubMed ID: 20660618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
